Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Embr Labs Continues Momentum as Leader in Thermal Wellness
  • USA - English

Digital therapeutics company attracts global consumer investor and leading women's health expert as Chief Medical Officer


News provided by

Embr Labs

Dec 03, 2020, 05:25 ET

Share this article

Share toX

Share this article

Share toX

BOSTON, Dec. 3, 2020 /PRNewswire-PRWeb/ -- Embr Labs, the breakthrough thermal technology company and creator of the Wave Bracelet, today announced a strategic investment by Joy Ventures and the appointment of Dr. Pamela Peeke as Embr Labs' Chief Medical Officer. Both moves help to solidify the company's leadership in women's health, wellness and digital therapeutics. The state of Massachusetts and the National Science Foundation recently recognized Embr Labs' role as a life sciences innovator by funding Artificial Intelligence for Menopause Symptoms, a collaboration between Embr Labs and UMass Institute for Applied Life Sciences that will produce the largest physiological dataset for natural menopause and advance the state of the art for detecting and predicting vasomotor symptoms, also known as hot flashes.

Dr. Pamela Peeke joins Embr Labs as Chief Medical Officer and will oversee clinical trials of the company's cutting-edge wearable that helps to improve women's stress, sleep and menopause symptoms. Dr. Peeke is a nationally renowned physician, scientist and expert in preventive and lifestyle medicine. She is also a Pew Foundation scholar in metabolism and a fellow of both the American College of Physicians and the American College of Sports Medicine, the latter of which she is a board member. As a three-time NY Times bestselling author and host of HER, the top women's health show on iTunes, Apple, and RadioMD, Dr. Peeke's message of health and wellness touches the lives of millions of women in the US and globally.

"As a physician and scientist, I am excited to be joining the Embr Labs' team. I look forward to creating clinical research opportunities and partnerships that will further the development and validation of this groundbreaking technology. At Embr Labs, we share a profound passion to improve people's health and wellbeing through our thermal digital technology. I'm honored and thrilled to be a part of this revolutionary new science," noted Dr. Pamela Peeke, Embr Labs' Chief Medical Officer.

As Embr Labs solidifies its leadership as a digital therapeutic company, the company has attracted global investors such as Joy Ventures, who are committed to advancing the growing category of consumer products for wellbeing. Joy Ventures' investment insight reflects an understanding that today's complex world combined with intense lifestyles has created stress, anxiety and life challenges that demand accessible and holistic solutions.

"At Joy Ventures, our mission is to counterbalance today's challenges by advancing the science of everyday joy. We work to identify the world's most talented entrepreneurs, innovators and scientists to evolve their ideas into products that will help us all live more joyfully - and we see Embr Labs as a company that is succeeding in this area," noted Miri Polachek, CEO of Joy Ventures.

Started in 2013 by three MIT materials science engineers, Embr Labs was founded upon a basic insight: temperature is an untapped pathway to the brain that can deliver therapeutic benefits. Embr's patented technology harnesses the power of thermal sensations to deliver safe, non-invasive, and beneficial therapies that leverage the body and mind's natural response to temperature to promote relief from hot flashes, manage stress, and improve sleep.

Embr Labs has sold tens of thousands of Embr Waves that have found their way into over 160 countries despite only being available through Embr Labs' US website. This digital thermal solution has also been clinically validated in partnership with Johnson & Johnson, and the Embr Labs' Science and Innovation team continues to explore new ways to enhance the efficacy and impact of Embr's technology for the nearly 1.1 billion women who will be experiencing menopause by the year 2025.

"The addition of Dr. Peeke to our leadership team and the investment from Joy Ventures, combined with our collaboration with UMass IALS and support from the Massachusetts Life Sciences Center/NSF have significantly accelerated our development and validation of innovative digital thermal solutions for women's health," said Elizabeth Gazda, CEO of Embr Labs.

For more information, please contact Heather Ritchie or [email protected], or visit embrlabs.com.

About Embr Labs
Embr Labs is the first thermal wellness technology company, pioneering a new pathway to unlock the therapeutic power of temperature. Its first product, Embr Wave, is an intelligent bracelet that uses temperature to activate and balance the body and mind. Despite only being sold in the United States, the Wave is being used in over 160 countries. The company's patented technology harnesses the power of thermal sensations to deliver a brand new category of safe, non-invasive, and natural therapies that leverage the body and mind's natural response to temperature to help people feel more comfortable, fall asleep faster, and be less stressed. Embr Labs was founded by MIT-trained engineers and is backed by investors including DigiTx Partners, Joy Ventures, Bose Ventures and Joyance Partners.

Media Contact

Heather Ritchie, Embr Labs, +1 (323) 903-7063, [email protected]

Twitter, Facebook

SOURCE Embr Labs

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.